FN1 and colorectal carcinoma: Br-J-I has potent antimicrobial activity and no cytotoxicity to CRC itself, and it significantly inhibits the growth of CRC promoted by Fn, suggesting that Br-J-I counteracts the adverse effects of Fn on CRC through its antimicrobial activity against Fn.